Skip to main content
Year archive

SYNTARA LIMITED — 2019 filings

All 48 regulatory filings released by SYNTARA LIMITED (SNT) in 2019, sourced directly from the official regulator.

48 Filings
2019 Period
2019 filings (48)
Filing Released Lang
Ceasing to be a substantial holder 5 pages 139.9KB
Major Shareholding Notification
2019-12-19 English
Boehringer discontinues development of BI 1467335 for NASH 2 pages 124.8KB
Regulatory Filings
2019-12-17 English
Pharmaxis Business Plan Update 2 pages 115.9KB
Capital/Financing Update
2019-12-17 English
Investor Conference Call 2 pages 108.0KB
Call Transcript
2019-12-16 English
Trading Halt 2 pages 105.1KB
Regulatory Filings
2019-12-15 English
Investor Presentation 18 pages 991.1KB
Investor Presentation
2019-11-24 English
Chairman's Address to Shareholders 2 pages 99.0KB
AGM Information
2019-11-20 English
CEO Presentation to 2019 AGM 22 pages 996.3KB
AGM Information
2019-11-20 English
Results of Meeting 2 pages 221.8KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-20 English
Appendix 3B - Issue of Employee Options 10 pages 133.7KB
Capital/Financing Update
2019-11-20 English
Change of Director's Interest Notice 2 pages 73.5KB
Director's Dealing
2019-11-20 English
Appendix 3B - Grant of Employee Options 10 pages 133.1KB
Capital/Financing Update
2019-11-05 English
Quarterly Shareholder Update - September 2019 9 pages 378.6KB
Interim / Quarterly Report
2019-10-30 English
Appendix 4C - quarterly 5 pages 125.7KB
Interim / Quarterly Report
2019-10-30 English
CEO Presentation to 2019 AusBiotech Conference 24 pages 2.1MB
Investor Presentation
2019-10-29 English
Pharmaxis Science Update - Anti-Fibrotic Pipeline 3 pages 127.8KB
Regulatory Filings
2019-10-29 English
FDA Provides Guidance on Bronchitol Approval Steps 2 pages 107.0KB
Regulatory Filings
2019-10-27 English
Pharmaxis Cancer Drug Progressing in Clinic 2 pages 160.6KB
Regulatory Filings
2019-10-23 English
Annual Report to shareholders 64 pages 799.6KB
Annual Report
2019-10-17 English
Notice of Annual General Meeting/Proxy Form 14 pages 330.6KB
AGM Information
2019-10-17 English
Corporate Governance Statement 18 pages 85.5KB
Governance Information
2019-10-17 English
Appendix 4G 13 pages 94.9KB
Governance Information
2019-10-17 English
Pharmaxis Receives $6.2m R&D Tax Incentive 2 pages 105.6KB
Capital/Financing Update
2019-10-16 English
Appendix 3B - Exercise of Employee Options 9 pages 131.8KB
Capital/Financing Update
2019-09-11 English
Preliminary Final Report 60 pages 891.1KB
Annual Report
2019-08-14 English
Lapse of 2018 Performance Rights and Expiry of Options 1
Regulatory Filings
2019-08-14 English
Change of Director's Interest Notice-G Phillips Rights Lapse 2 pages 73.4KB
Director's Dealing
2019-08-14 English
Appendix 3B 2019 Grant of Performance Rights and Share Plan 10 pages 134.2KB
Capital/Financing Update
2019-08-14 English
Proposed Issue of Securities to CEO 2 pages 115.0KB
Share Issue/Capital Change
2019-08-14 English
Investor Presentation 37 pages 1.6MB
Investor Presentation
2019-07-25 English
Appendix 4C - quarterly 5 pages 125.0KB
Interim / Quarterly Report
2019-07-24 English
Quarterly Shareholder Update - June 2019 11 pages 397.3KB
Interim / Quarterly Report
2019-07-24 English
Pathway to US Bronchitol Approval Clarified in FDA Response 2 pages 106.8KB
Regulatory Filings
2019-06-19 English
Change in substantial holding 5 pages 383.3KB
Regulatory Filings
2019-05-29 English
US Advisory Committee Positive Recommendation on Bronchitol 2 pages 138.9KB
Regulatory Filings
2019-05-08 English
Appendix 4C - quarterly 5 pages 127.6KB
Interim / Quarterly Report
2019-04-28 English
Quarterly Shareholder Update - March 2019 9 pages 388.2KB
Interim / Quarterly Report
2019-04-28 English
Appendix 3B - Exercise of Employee Options 9 pages 132.0KB
Share Issue/Capital Change
2019-04-17 English
Investor Presentation 30 pages 1.6MB
Investor Presentation
2019-03-31 English
US FDA Convenes Advisory Committee for Bronchitol 2 pages 104.4KB
Regulatory Filings
2019-03-25 English
Becoming a substantial holder 2 pages 263.1KB
Regulatory Filings
2019-03-04 English
Ceasing to be a substantial holder 1 page 10.8KB
Major Shareholding Notification
2019-03-03 English
Boehringer Completes Enrollment of Phase 2A Trial in NASH 2 pages 107.7KB
Regulatory Filings
2019-02-24 English
Pharmaxis Commences Phase 1 LOX Clinical Trial 2 pages 133.2KB
Regulatory Filings
2019-02-21 English
Half Yearly Report and Accounts 23 pages 568.1KB
Interim / Quarterly Report
2019-02-13 English
Appendix 4C - quarterly 5 pages 125.0KB
Interim / Quarterly Report
2019-01-29 English
Quarterly Shareholder Update - December 2018 9 pages 383.2KB
Interim / Quarterly Report
2019-01-29 English
Pharmaxis Announces LOXL2 Program Phase 2 Ready 2 pages 120.4KB
Regulatory Filings
2019-01-16 English